Novartis
To discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering.
Launch date
Employees
Market cap
CAD318.7b
Enterprise valuation
CAD346.8b (Public information from Sep 2024)
Share price
$115.97 NVS
Company register number CHE-106.054.058
Basel Canton of Basel-Stadt (HQ)
Corporate Venture Fund: dRx Capital, Novartis Venture Fund
No columns specified